Topic Description: Supplying clinical trials with drug & device combinations such as inhalers or auto-injectors adds a level of complexity. In addition to supplying and resupplying the drug, clinical supply managers must ensure that devices are accounted for as well. Some countries, such as Russia and Turkey, limit the number of devices that can be imported per number of patients expected to enrol in a trial.
On Thursday August 6th at 8am PT/11am ET/4pm BT, come chat with Rich Nelson & Slava Shulov about:
- Recommendations for combo drug & device kit design, packaging, and blinding
- The regulatory & logistical challenges that sponsors face globally
- Import & export concerns with combo drug & device kits
To register for this event, please click here: